Laboratory testing practices for west nile virus in the United States

Vector-Borne and Zoonotic Diseases

Volumn 11, Issue 5, 2011, Pages 597-599

  Janusz, Kristen B ^a   Lehman, Jennifer A ^a   Panella, Amanda J ^a   Fischer, Marc ^a   Staples, Erin ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

ELISA; IgM; Laboratories; United States; West Nile virus

Indexed keywords

ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD AND DRUG ADMINISTRATION; LABORATORY TEST; MONITORING; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; UNITED STATES; VIRUS DIAGNOSIS; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); ENZYME-LINKED IMMUNOSORBENT ASSAY; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULIN M; LABORATORIES; PUBLIC HEALTH; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WEST NILE FEVER; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 79957581746     PISSN: 15303667     EISSN: 15577759     Source Type: Journal    
DOI: 10.1089/vbz.2010.0058     Document Type: Article

References (10)

1. [CDC] Centers for Disease Control and Prevention. Laboratorydiagnosis. In: Epidemic/Epizootic West Nile Virus in the UnitedStates: Guidelines for Surveillance, Prevention, and Control. FortCollins, CO: US Department of Health and Human Services, CDC, 2003. Available at www.cdc.gov/ncidod/dvbid/westnile/ resources/wnvguidelines2003.pdf
2. [CDC] Centers for Disease Control and Prevention. CurrentCLIA regulations ?493.1256, ?493.1281(b), ?493.1282 (a and b),and ?493.1289. Atlanta, GA: US Department of Health andHuman Services, CDC, 2004. Available at wwwn.cdc.gov/clia/regs/toc.aspx
3. [CDC] Centers for Disease Control and Prevention. False-positive results with a commercially available West Nile virusimmunoglobulin M assay - United States, 2008. MMWR 2009;58:458-460.
4. Centers for Medicare & Medicaid Services. Clinical LaboratoryImprovement Amendments overview. Baltimore, MD: USDepartment of Health and Human Services, Centers forMedicare & Medicaid Services, 2009. Available at www.cms.hhs.gov/cliaFocus
5. Diagnostics, Inc. West Nile virus IgM capture DxSelectpackage insert. 2009. Available at www.focusdx.com/focus/packageinsert/el0300M.pdf
6. InBios International, Inc. West Nile detect IgM captureELISA package insert. 2004. Available at www.inbios.com/cms/file/900015- 2%20West%20Nile%20Detect%20IgM%20Capture%20ELISA%20Human%20Insert.pdf
7. Inverness Medical Innovations Australia Pty Ltd. PanBio WNVIgM capture ELISA test product overview 2005. Available at www.panbio.com/download/PB0057. pdf
8. Johnson, A, Cheshier, R, Cosentino, G, Masri, H, Mock, V,Oesterle, R, et al. Validation of a microsphere-based immu-noassay for detection of anti-West Nile virus and anti-St. Louisencephalitis virus immunoglobulin M antibodies. Clin VaccineImmunol 2007; 14:1084-1093. (Pubitemid 47518074)
9. Reimann, C, Hayes, E, DiGuiseppi, C, Hoffman, R, Lehman, J,Lindsey, N, et al. Epidemiology of neuroinvasive arboviraldisease in the United States, 1999-2007. Am J Trop Med Hyg 2008; 79:974-979.
10. Spectral Diagnostics, Inc. Spectral West Nile virus IgM test. 2006. Available at www.accessdata.fda.gov/cdrh-docs/pdf5/k052519.pdf